KennedyD., “Responding to Fraud,”Science314, no. 5804 (2006): 1353.
2.
Institute of Medicine, Committee on Assessing the System for Protecting Human Research Participants
3.
FedermanD. D.HannaK. E.RodriguezL. L., eds., Responsible Research: A Systems Approach to Protecting Research Participants (Washington, D.C.: National Academies Press, 2002).
4.
NBAC, the DHHS Office of Inspector General, the General Accounting Office, the Advisory Committee on Human Radiation Experiments, the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, and the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, as cited in Responsible Research: A Systems Approach to Protecting Research Participants, 2003.
5.
Department of Health & Human Services, Office of Inspector General, “Draft OIG Compliance Program Guidance for Recipients of PHS Research Awards,” U.S. Government Printing Office, Washington, D.C., 2005, available at <http://oig.hhs.gov/fraud/docs/complianceguidance/PHSResearchAwardsDraftCPG.pdf> (last visited May 12, 2011).
6.
GrantG.GuytonO.ForresterR., “Creating Effective Research Compliance Programs in Academic Institutions,”Academic Medicine74, no. 9 (1999): 951–971.
7.
HeathE., “The IRB's Monitoring Function: Four Concepts of Monitoring,”IRB: Ethics and Human Research1, no. 5 (1979): 1–3 and 12.
8.
WeijerC.ShapiroS.FuksA.GlassK. C.SkrutkowskaM., “Monitoring Clinical Research: An Obligation Unfulfilled,”Canadian Medical Association Journal152, no. 12 (1995): 1973–1980.
9.
GreeneS. M.GeigerA. M., “A Review Finds that Multicenter Studies Face Substantial Challenges but Strategies Exist to Achieve Institutional Review Board Approval,”Journal of Clinical Epidemiology59, no. 8 (2006): 784–790.
10.
JonesJ.WhiteL.PoolL.DoughertyJ., “Structure and Practice of Institutional Review Boards in the United States,”Academic Emergency Medicine3, no. 8 (1996): 804–809.
11.
ParsonsT., The Social System (Glencoe, Ill.: Free Press, 1951).
12.
StevensonA.SiefringJ.BrownL.TrumbleW. R., eds., Oxford English Dictionary (Oxford: Oxford University Press, 2002).
13.
U.S. Department of Health and Human Services, Office of Research Integrity, “Research – Extramural,” retrieved September 8, 2005, available at <http://ori.hhs.gov/research/extra/index.shtml> (last visited May 12, 2011).
KorenmanS. G.BerkR.WengerN. S.LewV., “Evaluation of the Research Norms of Scientists and Administrators Responsible for Academic Research Integrity,”JAMA279, no. 1 (1998): 41–47.
16.
MelloM.ClarridgeB.StuddertD., “Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry,”New England Journal of Medicine352, no. 21 (2005): 2202–210
17.
KoocherG.Keith-SpeigelP., IRB Researcher Assessment Tool (IRB-RAT): A User's Guide (Boston: Harvard Medical School, 2005).
18.
Office of Inspector General, “Institutional Review Boards: Their Role in Reviewing Approved Research,”DHHS Publication No. OEI-01-97-00190, Washington, D.C., U.S. Government Printing Office (1998a)
19.
Office of Inspector General, “Institutional Review Boards: Promising Approaches,”DHHS Publication No. OEI-01-91-00191, Washington, D.C., U.S. Government Printing Office (1998b)
20.
Office of Inspector General, “Institutional Review Boards: The Emergence of Independent Boards,”DHHS Publication No. OEI-01-97-00192, Washington, D.C., U.S. Government Printing Office (1998c)
21.
Office of Inspector General, Department of Health and Human Services, “Institutional Review Boards: A Time for Reform,” DHHS Publication No. OEI-01-97-00193, Washington, D.C., U.S. Government Printing Office (1998d)
22.
Office of Inspector General, “Protecting Human Research Subjects: Status of Recommendations,”DHHS Publication No. OEI-01-97-00197, Washington, D.C., U.S. Government Printing Office (2000a)
23.
Office of Inspector General, “Recruiting Human Subjects: Pressure in Industry-Sponsored Clinical Research,”DHHS Publication No. OEI-01-97-00195, Washington, D.C., U.S. Government Printing Office (2000b)
24.
Office of Inspector General, “Recruiting Human Subject: Sample Guidelines for Practice,”DHHS Publication No. OEI-01-97-00196, Washington, D.C., U.S. Government Printing Office (2000c)
25.
ffice of Inspector General, “Clinical Trial Web Sites: A Promising Tool to Foster Informed Consent,”DHHS Publication No. OEI-01-97-00198, Washington, D.C., U.S. Government Printing Office (2002)
26.
MorenoJ.CaplanA.WolpeP., and the Members of the Project on Informed Consent, Human Research Ethics Group, “Updating Protections for Human Subjects Involved in Research,”Journal of the American Medical Association280, no. 22 (1998): 1951–1958
27.
BurmanW.RevesR.CohnD.SchooleyR., “Breaking the Camel's Back: Multicenter Clinical Trials and Local Institutional Review Boards,”Annals of Internal Medicine134, no. 2 (2001): 152–157.
28.
CampbellE. G.WeissmanJ. S.ClarridgeB.YucelR.CausinoN.BlumenthalD., “Characteristics of Medical School Faculty Members Serving on Institutional Review Boards: Results of a National Survey,”Academic Medicine78, no. 8 (2003): 831–836.
29.
GreeneS. M.GeigerA. M., “A Review Finds That Multicenter Studies Face Substantial Challenges but Strategies Exist to Achieve Institutional Review Board Approval,”Journal of Clinical Epidemiology59, no. 8 (2006): 784–790.
30.
KlitzmanR., “How Local IRBs View Central IRBs in the US,”BMC Medical Ethics12, no. 13 (2011).
31.
KlitzmanR., “‘Members of the Same Club’: Challenges and Decisions Faced by US IRBs in Identifying and Managing Conflicts of Interest,”PLoS ONE (in press).
32.
KlitzmanR., “The Myth of Community Diferences as the Cause of Variations among IRBs,”AJOB Primary Research (in press).
33.
KlitzmanR., “US IRBs Confronting Research in the Developing World,”Developing World Bioethics (in press).
34.
See Klitzman, supra note 19;
35.
Klitzman, supra note 21.
36.
GeertzC., Interpretation of Cultures: Selected Essays (New York: Basic Books, 1973).
37.
StraussA.CorbinJ., Basics of Qualitative Research – Techniques and Procedures for Developing Grounded Theory (Newbury Park: Sage Publications, 1990).
38.
See Jones, supra note 9.
39.
Id.
40.
LeonardN. H.BeauvaisL. L.SchollR. W., “Work Motivation: The Incorporation of Self-Concept-Based Processes,”Human Relations52, no. 8 (1999): 969–998.
41.
See Jones, supra note 9
42.
KoocherG. P., “The IRB Paradox: Could the Protectors Also Encourage Deceit?”Ethics & Behavior15, no. 4 (2005): 339–349.
43.
MertonR. K., “Social Structure and Anomie,”American Sociological Review3, no. 5 (1938): 672–682.
44.
See Kennedy, supra note 1.
45.
TylerT.KramerR., “Whither Trust?” in KramerR.TylerT., eds., Trust in Organizations (Thousand Oaks, Calif.: Sage, 1996)
46.
HardinR., Trust and Trustworthiness (New York: Russell Sage Foundation, 2002)
47.
NagelT., “Concealment and Exposure,”Philosophy and Public Affairs27, no. 1 (1998): 3–30.
48.
CallahanE. S.DworkinT. M., “The State of State Whistleblower Protection,”American Business Law Journal38, no. 1 (2000): 99–175.
49.
KatzD.KahnR. L., The Social Psychology of Organizations (New York: Wiley, 1996).